Drosophila melanogaster (Clark, 1953) ; it also inhibits tumor induction on mouse skin in two-stage carcinogenesis , and causes photodynamic inactivation of tobacco mosaic virus (Sastry and Gordon, 1966) and other viruses. Moreover, acridine orange has been shown to inhibit protein and nucleic acid biosynthesis in cell culture systems (Zelenin and Liapunova, 1964; Scholtissek and Becht, 1966) .
Because of these varied properties, the mode of interaction of the dye with nucleic acids, particularly DNA, has been widely studied by a variety of physical methods (Van Duuren, 1969) and several modes of binding of dye to nucleic acid have been proposed (Drummond et al., 1965) .
The relationship between the mode of action of carcinogens, mutagens and tumor-initiating agents is a problem of continuing interest (Trainin et al., 1964; Van Duuren and Sivak, 1968) . Since little is known about the tumor-initiating and carcinogenic activity of acridine orange, it was of interest to examine these properties in mice and rats. The present report gives the results of these experiments.
MATERIALS AND METHODS
Animals. Mice were ICR/Ha Swiss obtained from Millerton Research Farms (Millerton, N.Y.) . Females were used in all experiments. The mice were vaccinated against ectromelia at age 6 weeks and started on test at age 8 weeks. All mice were housed on sterilized wood chips in metal cages, 10 to a cage. Rats were female eastern Sprague-Dawley obtained from Blue Spruce Farms (Altamont, N.Y.). The rats were 6 weeks old and weighed 120-125 g. when testing began. They were housed in suspended wire mesh cages, 2 to a cage. Both mice and rats were fed Purina Laboratory Chow and water ad libitum. The animal rooms were temperature controlled at 22-24°C.
Biological testing methods. Animals were weighed and observed monthly for the duration of the experiment. Tumors were recorded and counted at each observation. Any animal judged clinically to be in poor condition was sacrificed before the end of the experiment. All animals were examined carefully postmortem and tumors and other lesions were excised for histological examination. Tissue sections were fixed in 10% formalin, blocked in paraffin and stained with hematoxylin and eosin. Routine sections of liver were also taken in the mouse skin treatment groups which received acridine orange repeatedly. Phorbol myristate acetate. The preparation of this material was described earlier (Van Duuren and Orris, 1965) .
RESULTS
The results of a series of experiments using mouse skin as the site of application are given in Table I . In these experiments A.O. was tested as: (a) an initiating agent, i.e. a single application of A.O. followed by repeated application of a potent tumor-promoting agent, phorbol myristate acetate (Van Duuren and Orris, 1965) ; (b) a promoting agent, i.e. a single application of 7,12-dimethylbenz(a)anthracene (DMBA), followed by repeated application of the dye, and (c) as a skin carcinogen by repeated application of the dye only. Appropriate control groups were included in the experiment as shown in Table I observed with the promoting agent alone (Van Duuren, 1968) so that it has to be concluded that the mutagen acridine orange is not an initiating agent for mouse skin. Also it is not carcinogenic for mouse skin. The most intriguing finding was that A.O. applied repeatedly after a single dose of DMBA markedly augmented the tumor incidence normally observed with 150 ,tg. of DMBA alone. However, the tumors appeared late, 322 days to first papillomas. Although not carcinogenic for mouse skin, it is noteworthy that skin application of A.O. resulted in 3 of a total of 20 animals with liver tumors suggesting systemic absorption through the skin.
The dye was also tested for carcinogenic activity by subcutaneous injection in mice and rats. These results are shown in Table II . In the group of 30 mice, 2 bore local tumors, a fibrosarcoma and a lymphoma; of 20 rats only one bore a local tumor which was a reticulum cell sarcoma. No distant tumors were observed in any of the treatment groups. In no-treatment groups in which the median survival time was 469 days, a normal incidence (Van Duuren et al., unpublished data) of spontaneous tumors was observed; these tumors were lymphomas, adenomas and reticulum cell sarcomas.
DISCUSSION
In earlier studies with a series of epoxides and related compounds, we have compared carcinogenicity and mutagenicity (Van Duuren et al., 1965) . Using data obtained from our own work and the literature, we have also compared these two properties with tumor-initiating activity for a series of 18 diverse compounds (Van Duuren and Sivak, 1968) . No clearcut correlations could be drawn from such comparative lists. One of the difficulties in making such comparisons is that until recently mutagenicity was usually tested in microbial systems, phage or Drosophila; whereas, carcinogenicity and tumor initiation are usually examined in mammalian systems.
Based on the present work, acridine orange is not carcinogenic for mouse skin, is not an initiating agent and is, at best, a borderline carcinogen by subcutaneous injection. It has not been tested for mutagenicity in mammalian systems, but the closely related dye, acriflavine, was tested by the dominant lethal assay in mice and found to be inactive (Bateman, 1966; Epstein and Shafner, 1968) . Proflavine, another related dye, had a low mutagenicity index in a human cell culture system (Szybalski, 1964) . Trainin et al. (1964) described the assay of 10 mutagenic compounds for initiating activity. The initiating agent was given by intraperitoneal injection followed by skin application of croton oil; acridine orange was included in this series. Of the 10 mutagens tested only urethane showed initiating activity for mouse skin. Similar findings with other mutagens were obtained earlier by Roe (1957) .
Thus, the direct correlation between carcinogenicity and mutagenicity implied by the somatic mutation theory of carcinogenesis is not fulfilled when the available data are considered. The recent development of effective mutagenic assays in mammalian systems should provide more definitive answers than are now available with respect to the relationships in question (Kao and Puck, 1967) .
SUMMARY
The mutagen acridine orange was tested for initiating, promoting, and carcinogenic activity on mouse skin and for carcinogenesis by subcutaneous injection in mice and rats. The dye is neither an initiating agent nor a carcinogen for mouse skin. When applied on skin it induces liver tumors in mice and when given subcutaneously in mice and rats, it induces a small number of tumors at the injection site in both species.
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